As a means to support creative, interdisciplinary researchers in expansion of their Regenerative Rehabilitation research, we have established the AR3T Pilot Funding Program.
This program encourages new collaborations between regenerative medicine and rehabilitative medicine researchers; and supports the development of novel Regenerative Rehabilitation paradigms with the potential to improve patient health outcomes. Funds are distributed to investigators either working independently or in collaboration with one of the AR3T participating laboratories.
The proposed project must include both a regenerative medicine component as well as a rehabilitative component.
- The AR3T pilot funding program is open to junior investigators and mid-level career faculty working in the United States. The goal is to provide support for researchers who are interested in beginning a career in Regenerative Rehabilitation research or who would like to start a new line of research in this area.
- Up to $150,000 will be distributed for the 2017 AR3T funding cycle.
- Pilot awards will range from $15,000-$65,000.
- Total award includes indirect costs by the awardee’s institution.
Examples of funded pilot projects include:
- Zena Vexler (UCSF): The extracellular matrix as a negative modulator of repair after neonatal focal arterial stroke
- Shawn Russell (UVA): Quantifying the impact of tibialis anterior (TA) volumetric muscle loss (VML) injuries on rat gait deficits and the degree of functional recovery following repair with engineered muscle tissue
- Andrew Brack (UCSF): Antibody-directed inhibition of GDF11 to boost skeletal muscle repair
- Michael Modo (University of Pittsburgh): Neuro-biological effects of rehabilitation on neural stem cell transplantation after stroke
- Sarah Heilshorn (Stanford): Protein-engineered nerve guidance conduits for peripheral nerve injury recovery and rehabilitation
- Jarrod Call (UGA) and Sarah Greising (USAISR): Early interventions for orthopedic combat casualties
- Joseph Roche (Wayne State): Novel rehabilitative interventions for muscle loss
- Ngan Huang and Karina Nakayama (PAVIR): Nano-aligned scaffold conjugated with insulin-like growth factor-1 mRNA for treatment of volumetric muscle loss
Review the application process and review criteria for more information.
Access the online pilot application.
The next RFA will be Fall 2017.
For questions and/or assistance with proposal development, contact us at email@example.com.